Stock Information
Vir Biotechnology Inc (VIR)
Ticker Symbol: VIR
Exchange: NASDAQ
Sector: Biotechnology
Market Cap: $1,905.77 mil
Piotroski score: 7
PE Ratio: N/A
EPS (TTM): -1.01
Revenue (TTM): $1.80 M
Dividend Yield: N/A
ROE: -14.86%
Latest News
-
Vir Biotechnology Announces PSMA-targeted PRO-XTEN® Dual-masked T-cell Engager VIR-5500 Received FDA Fast Track Designation for the Treatment of Prostate Cancer
Thu, Oct 8, 2026 12:30 PM
-
Vir Biotechnology Receives FDA Fast Track Designation For VIR-5500 To Treat Metastatic Castration-Resistant Prostate Cancer
Thu, Oct 8, 2026 8:33 AM
-
How Upcoming SOLSTICE Phase 2 HDV Data Could Shape Vir Biotechnology’s (VIR) Investment Narrative
Thu, Oct 8, 2026 6:13 AM
-
Vir Biotechnology Appoints David Liu as Chief Medical Officer
Wed, Oct 7, 2026 12:30 PM
-
HC Wainwright & Co. Maintains Buy on Vir Biotechnology, Raises Price Target to $22
Wed, Oct 7, 2026 10:21 AM
Key Financials
Financial data not available
